Close Menu

GTAC

As director of the Genome Technology Access Center at the Washington University School of Medicine in St. Louis, Seth Crosby has first-hand experience with dealing with researchers who want to use next-gen sequencing, but whose projects are more likely to succeed with arrays.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.